Standigm
PrivateLast Round
Series C
Extension
Jul 2, 2021
Est. Valuation
$200M
Total Funding Raised
$92.13M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Standigm is a biotechnology company that provides an AI-based platform for drug discovery and development.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Standigm Comparables
Compare Standigm with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| PharmCADD Co., Ltd. | 88% | |
| Iktos | 86% | |
| Arontier | 79% |
Standigm Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C Extension | Jul 2, 2021 | ||||
| Strategic | Jul 1, 2021 | ||||
| Series C | Mar 5, 2021 | ||||
| Strategic | Nov 18, 2019 | ||||
| Series B | Mar 4, 2019 | ||||
Series A | Aug 1, 2016 |
Key People
Founding team and executive leadership
Standigm Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| InterVest | Series C |
| DSC Investment | Series C, Series B |
| Kakao Ventures | Series A, Series C, Seed, Series B |
| Tantan Global Partners | Series C |
| SK Inc. | Strategic |
| Wonik Investment Partners | Series C, Series B |
| Pavilion Capital | Series C, Series C Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 113% MoM, from 562 to 1.2K.
- Apr 15, 2026
Monthly visitors grew 381% MoM, reaching 3.6K.
Standigm Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Standigm's valuation, stock price, and market status.
Is Standigm a public or private company?
Standigm is a private company.
What is the current stock price of Standigm?
Standigm is a private company with no public stock price. No recent secondary market data is available.
How much is Standigm worth (valuation)?
Standigm's valuation is estimated at $178.0M based on funding round data.
Can I buy Standigm stock?
Standigm shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Standigm's last funding round?
Standigm's most recent funding round was Series C Extension on March 5, 2021.
Who are the main investors in Standigm?
Key investors in Standigm include Kakao Ventures, Pavilion Capital, SKS Private Equity, Daishin Private Equity, Mirae Asset Capital.
Will Standigm IPO soon?
No public IPO plans have been announced for Standigm.
How can I track Standigm secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Standigm's secondary market activity and sign up for updates.